This metabolite has a PDE selectivity profile much like sildenafil and an in vitro potency for PDE5 close to 50% from the mum or dad drug. Plasma concentrations of the metabolite are roughly 40% of those seen for sildenafil, so that the metabolite accounts for around 20% of sildenafil’s pharmacologi